Incyte Corp (INCY)
51.92
-0.43
(-0.82%)
USD |
NASDAQ |
Apr 22, 16:00
51.91
-0.01
(-0.02%)
After-Hours: 20:00
Incyte Free Cash Flow: 449.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 449.00M |
| September 30, 2023 | 565.93M |
| June 30, 2023 | 697.64M |
| March 31, 2023 | 560.86M |
| December 31, 2022 | 892.11M |
| September 30, 2022 | 710.61M |
| June 30, 2022 | 664.98M |
| March 31, 2022 | 609.20M |
| December 31, 2021 | 568.48M |
| September 30, 2021 | 543.48M |
| June 30, 2021 | 449.83M |
| March 31, 2021 | 568.72M |
| December 31, 2020 | -311.98M |
| September 30, 2020 | -265.56M |
| June 30, 2020 | -107.63M |
| March 31, 2020 | -227.49M |
| December 31, 2019 | 632.59M |
| September 30, 2019 | 588.85M |
| June 30, 2019 | 475.95M |
| March 31, 2019 | 391.89M |
| December 31, 2018 | 262.74M |
| September 30, 2018 | 89.67M |
| June 30, 2018 | -65.84M |
| March 31, 2018 | -1.156M |
| December 31, 2017 | -204.01M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.98M |
| June 30, 2017 | 48.84M |
| March 31, 2017 | -102.10M |
| December 31, 2016 | 184.48M |
| September 30, 2016 | 171.96M |
| June 30, 2016 | 87.68M |
| March 31, 2016 | 163.52M |
| December 31, 2015 | 63.40M |
| September 30, 2015 | 36.28M |
| June 30, 2015 | 59.05M |
| March 31, 2015 | 24.60M |
| December 31, 2014 | -1.62M |
| September 30, 2014 | -54.20M |
| June 30, 2014 | -84.07M |
| March 31, 2014 | -53.29M |
| December 31, 2013 | 4.913M |
| September 30, 2013 | -4.305M |
| June 30, 2013 | -19.12M |
| March 31, 2013 | -18.93M |
| December 31, 2012 | -97.67M |
| September 30, 2012 | -115.50M |
| June 30, 2012 | -136.11M |
| March 31, 2012 | -175.64M |
| December 31, 2011 | -165.51M |
| September 30, 2011 | -100.08M |
Free Cash Flow Range, Past 5 Years
-311.98M
Minimum
Dec 2020
892.11M
Maximum
Dec 2022
424.50M
Average
565.93M
Median
Sep 2023
Free Cash Flow Benchmarks
| Novartis AG | 11.70B |
| MorphoSys AG | -- |
| Illumina Inc | 282.00M |
| Biogen Inc | 1.236B |
| Pfizer Inc | 4.793B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 147.73M |
| Cash from Investing (Quarterly) | -154.50M |
| Cash from Financing (Quarterly) | 0.346M |
| Free Cash Flow Per Share (Quarterly) | 0.6424 |
| Free Cash Flow to Equity (Quarterly) | 145.46M |
| Free Cash Flow to Firm (Quarterly) | 145.46M |
| Free Cash Flow Yield | 3.83% |